Shields et al. developed a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes; they advised that their model should be used in all patients diagnosed with diabetes under the age of 35, who are not treated with insulin within 6 months of diagnosis; posttest probabilities of >25% would be appropriate to trigger genetic testing [8]. This evidence concerns the gene INS and MODY.